THROMBOTIC MICROANGIOPATHY IN ASSOCIATION WITH CYTOMEGALOVIRUS INFECTION IN A RENAL TRANSPLANT PATIENT
- 1 June 1998
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 65 (12) , 1645-1648
- https://doi.org/10.1097/00007890-199806270-00018
Abstract
Cytomegalovirus (CMV) associated with thrombotic microangiopathy (TMA) in transplant patients has not been extensively described. This case illustrates an association between CMV and TMA in a transplant patient with resolution of the latter after treatment of the CMV. At 6 weeks after renal transplantation, a 57-year-old woman presented with TMA. Cyclosporine was discontinued, and plasmapheresis was started. However, the patient continued to deteriorate and developed CMV pneumonitis. Plasmapheresis was discontinued, and intravenous ganciclovir was initiated. Both the TMA and the CMV resolved after initiation of the ganciclovir. This case identifies another potential etiological factor in the development of TMA after renal transplantation. It is the first reported case of TMA being cured with treatment of CMV.Keywords
This publication has 4 references indexed in Scilit:
- Thrombotic Microangiopathy and Cytomegalovirus Disease in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1997
- Human Cytomegalovirus Immediate Early And Late Transcripts In Peripheral Blood Leukocytes: Diagnostic Value In Renal Transplant RecipientsThe Journal of Infectious Diseases, 1995
- Transplant-Associated Thrombotic Microangiopathy: The Role of IgG Administration as Initial TherapyAmerican Journal of Kidney Diseases, 1994
- Circulating Cytomegalovirus (CMV)-Infected Endothelial Cells in Patients with an Active CMV InfectionThe Journal of Infectious Diseases, 1993